Molecular epidemiology, antifungal susceptibility and virulence factors of Candida glabrata complex strains in Kayseri/Turkey

被引:7
|
作者
Kaan, Ozge [1 ]
Koc, A. Nedret [1 ]
Atalay, Mustafa Altay [1 ]
Sariguzel, Fatma Mutlu [1 ]
机构
[1] Erciyes Univ, Sch Med, Dept Med Microbiol, Kayseri, Turkey
关键词
Candida glabrata complex; Antifungal susceptibility; Molecular epidemiology; Sequence analysis; Virulence; SPP; PHOSPHOLIPASE; BRACARENSIS; PREVALENCE; YEASTS;
D O I
10.1016/j.micpath.2021.104870
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Candida nivariensis and Candida bracarensis are included in Candida glabrata complex, which are usually misidentified as C. glabrata based on phenotypic identification methods. It was aimed to identify C. glabrata complex isolated from various clinical samples in Kayseri/Turkey to the species level and to determine antifungal susceptibilities, virulence factors, and molecular epidemiology. Methods: Eighty three C. glabrata complex strains were studied in this study. Strains were phenotypically and molecularly identified. Phylogenetic analysis was done by the neighbor-joining method. Proteinase, phospholipase, esterase enzyme activity, and biofilm formation of strains were determined phenotypically. Antifungal susceptibility of strains were determined according to M60-Ed2 recommendations. Results: All the 83 strains identified as C. glabrata complex by phenotypic tests were confirmed as C. glabrata sensu stricto (C. glabrata) by PCR amplification and sequence analysis, but other complex members C. nivariensis and C. bracarensis were not detected. Phylogenetic analysis results revealed 19 different genotypes. No clonal relationship was detected among the strains. Biofilm formation in 75.9% of strains and esterase activity in 7.2% were found positive. Antifungal resistance rates of strains were determined as 9.2% for fluconazole and 45.8% for itraconazole; 43.4% of the strains for voriconazole were determined as non-wild type. Conclusion: It was determined that biofilm and esterase activity might play an active role in the virulence of C. glabrata. In addition, high resistance rates to azoles in C. glabrata strains isolated in our hospital at Kayseri/ Turkey emphasized the significance of epidemiological studies.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina
    Eugenia Morales-Lopez, Soraya
    Taverna, Constanza G.
    Eugenia Bosco-Borgeat, Maria
    Maldonado, Ivana
    Vivot, Walter
    Szusz, Wanda
    Garcia-Effron, Guillermo
    Cordoba, Susana B.
    MYCOPATHOLOGIA, 2016, 181 (11-12) : 871 - 878
  • [42] Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina
    Soraya Eugenia Morales-López
    Constanza G. Taverna
    María Eugenia Bosco-Borgeat
    Ivana Maldonado
    Walter Vivot
    Wanda Szusz
    Guillermo Garcia-Effron
    Susana B. Córdoba
    Mycopathologia, 2016, 181 : 871 - 878
  • [43] Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex
    Nogueira Brilhante, Raimunda Samia
    Santos Rodrigues, Terezinha de Jesus
    Collares Maia Castelo-Branco, Debora de Souza
    Cordeiro Teixeira, Carlos Eduardo
    Macedo, Ramila de Brito
    Bandeira, Silviane Praciano
    de Alencar, Lucas Pereira
    Monteiro, Andre Jalles
    Cordeiro, Rossana de Aguiar
    Pinheiro Gomes Bandeira, Tereza de Jesus
    Bezerra Moreira, Jose Luciano
    Costa Sidrim, Jose Julio
    Gadelha Rocha, Marcos Fabio
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 1568 - 1572
  • [44] Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates
    Arastehfar, Amir
    Daneshnia, Farnaz
    Najafzadeh, Mohammad Javad
    Hagen, Ferry
    Mahmoudi, Shahram
    Salehi, Mohammadreza
    Zarrinfar, Hossein
    Namvar, Zahra
    Zareshahrabadi, Zahra
    Khodavaisy, Sadegh
    Zomorodian, Kamiar
    Pan, Weihua
    Theelen, Bart
    Kostrzewa, Markus
    Boekhout, Teun
    Lass-Floerl, Cornelia
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [45] Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens
    Beatriz Virgínia da Silva
    Larissa Beatriz Silva
    Diego Batista Carneiro de Oliveira
    Paulo Roberto da Silva
    Kennio Ferreira-Paim
    Leonardo Euripides Andrade-Silva
    Mario León Silva-Vergara
    Anderson Assunção Andrade
    Mycopathologia, 2015, 180 : 333 - 343
  • [46] Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens
    da Silva, Beatriz Virginia
    Silva, Larissa Beatriz
    Carneiro de Oliveira, Diego Batista
    da Silva, Paulo Roberto
    Ferreira-Paim, Kennio
    Andrade-Silva, Leonardo Euripides
    Silva-Vergara, Mario Leon
    Andrade, Anderson Assuncao
    MYCOPATHOLOGIA, 2015, 180 (5-6) : 333 - 343
  • [47] Biodiversity, virulence factors and antifungal susceptibility of clinical isolates of Candida parapsilosis sensu lato
    Ortega-Riveros, M.
    Miranda-Zapico, I.
    Eraso, E.
    Quindos, G.
    MYCOSES, 2009, 52 : 55 - 55
  • [48] Candida glabrata: In vitro susceptibility of 84 isolates to eight antifungal agents
    Arias, A
    Arevalo, MP
    Andreu, A
    Rodriguez, C
    Sierra, A
    CHEMOTHERAPY, 1996, 42 (02) : 107 - 111
  • [49] Molecular epidemiology of Candida glabrata blood culture isolates
    Klotz, U.
    Willinger, B.
    Rath, P. -M.
    Steinmann, J.
    MYCOSES, 2015, 58 : 62 - 63
  • [50] Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes
    Ruan, Sheng-Yuan
    Huang, Yu-Tsung
    Chu, Chen-Chen
    Yu, Chong-Jen
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (03) : 236 - 239